Xiamen Amoytop Biotech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	827.6	555.45	287.02	181.2
Depreciation & Amortization	65.72	58.69	48.07	43.15
Other Amortization	27.73	9.53	2.3	1.18
Loss (Gain) From Sale of Assets	0.03	0.87	-0.03	1.8
Asset Writedown & Restructuring Costs	-	12.76	-	-
Loss (Gain) From Sale of Investments	-4.94	-6.2	-3.92	-6.78
Provision & Write-off of Bad Debts	3.72	0.35	-1.41	-2.34
Other Operating Activities	0.48	1.72	0.59	1.58
Change in Accounts Receivable	-404.83	-205.76	-15.51	-24.54
Change in Inventory	-76.53	-57.29	-13.24	-16.87
Change in Accounts Payable	0.45	153.19	61.89	63.92
Change in Other Net Operating Assets	16.1	-	-	-
Operating Cash Flow	430.63	512.1	363.16	234.78
Operating Cash Flow Growth	-15.91%	41.01%	54.68%	153.52%
Capital Expenditures	-251.35	-288.46	-219.17	-190.93
Sale of Property, Plant & Equipment	0.03	0.04	0.11	0.34
Investment in Securities	-57.29	-17.35	-70.34	78.66
Other Investing Activities	-	-	-	0.09
Investing Cash Flow	-308.62	-305.76	-289.4	-111.84
Short-Term Debt Issued	-	-	-	10
Total Debt Issued	-	-	-	10
Short-Term Debt Repaid	-	-	-10	-18.92
Long-Term Debt Repaid	-6.23	-6.26	-7.69	-4.61
Total Debt Repaid	-6.23	-6.26	-17.69	-23.53
Net Debt Issued (Repaid)	-6.23	-6.26	-17.69	-13.53
Common Dividends Paid	-166.79	-86.65	-40.68	-20.68
Financing Cash Flow	-173.02	-92.91	-58.37	-34.2
Foreign Exchange Rate Adjustments	-0.13	-1.11	0.03	-0.49
Net Cash Flow	-51.14	112.32	15.42	88.25
Free Cash Flow	179.28	223.64	143.99	43.85
Free Cash Flow Growth	-19.84%	55.31%	228.34%	-
Free Cash Flow Margin	6.36%	10.65%	9.43%	3.87%
Free Cash Flow Per Share	0.44	0.55	0.36	0.11
Cash Income Tax Paid	228.82	168.12	112.85	71.33
Levered Free Cash Flow	-44.25	41.08	127.17	11.47
Unlevered Free Cash Flow	-43.96	41.4	127.56	12.14
Change in Working Capital	-489.7	-121.08	30.53	14.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.